BioNTech (BNTX) Stock Price, Quote, News & History | Benzinga

BioNTech SE (BNTX) Stock Price, Quote, News & History

BNTXNASDAQ

Trade with Public

Trade with Public

$94.26

3.043.33%

At close: Jun 26, 5:00 PM EST

$94.21

2.993.28%

Pre-Market: 4:45 AM EST

OverviewNews Earnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

-

Close

$94.26

Volume / Avg.

1.52K / 947.11K

Day Range

- - -

52 Wk Range

79.52 - 124.00

Market Cap

$23.82B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

4.01%

Days to Cover

2.34

Recent Biontech SE News

BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape

BioNTech shares fall after Q1 revenue miss and wider net loss, despite lower-than-expected loss and long-term cost-saving plans.

Vandana Singh

Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'

Elon Musk raises concerns over COVID-19 vaccine dosage, citing a severe reaction that nearly led to hospitalization.

Namrata Sen

Why Is Pfizer Stock Dropping Tuesday?

Pfizer Inc (NYSE:PFE) shares are trading lower on Tuesday after the company and its COVID-19 vaccine partner paused an updated-shot trial.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

815.70M

Investing Cash Flow (TTM)

-1.06B

Financing Cash Flow (TTM)

-12.70M

Free Cash Flow (TTM)

605.90M

Capital Expenditure (TTM)

-209.80M

Net Change in Cash (TTM)

-261.70M

Analyst Trends and Forecast

1

Jan

6

Mar

2

Apr

3

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.51B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.23

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-6.13%

Earnings Yield % (FWD)

-4.88%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

33.46

Book Value / Share

-

Company Debt

Total Debt

$77.40M

LT Debt

$66.60M

LT Debt Issuance (TTM)

$45.10M

LT Debt Repayment (TTM)

-$55.80M

Total Cash

$9.94B

Debt to Equity

0.02

Issuance of Debt (TTM)

-$10.70M

Repayment of Debt (TTM)

-$55.80M

Key Statistics

Open

-

Close

$94.26

Volume / Avg.

1.52K / 947.11K

Day Range

- - -

52 Wk Range

79.52 - 124.00

Market Cap

$23.82B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

4.01%

Days to Cover

2.34

About

Sector

Health Care

Industry

Biotechnology

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several c...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy BioNTech (BNTX) stock?

A

You can purchase shares of BioNTech (NASDAQ:BNTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioNTech (BNTX) competitors?

A

There are no as such competitors for BioNTech.

Q

What is the forecast, or price target, for BioNTech (BNTX) stock?

A

BioNTech has a consensus price target of $132.74.

Q

What is the current price for BioNTech (BNTX)?

A

The stock price for BioNTech (NASDAQ: BNTX) is $94.21 last updated June 30, 2026 at 3:54 AM EDT.

Q

Does BioNTech (BNTX) pay a dividend?

A

There are no upcoming dividends for BioNTech.

Q

When is BioNTech (NASDAQ:BNTX) reporting earnings?

A

BioNTech does not have any upcoming earnings scheduled.

Q

Is BioNTech (BNTX) going to split?

A

There is no upcoming split for BioNTech.

Q

What sector and industry does BioNTech (BNTX) operate in?

A

BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.